North America Startup Funding Rounds

Celero develops coherent digital signal processors and analog technology for optical links that connect AI accelerators and data centers. Its validated 2nm silicon architecture is designed to move more data across scale-up, scale-out and data-center links with lower power and a path from 1.6T to next-generation 3.2T connectivity.

An agent-led growth platform measures whether AI agents can discover, evaluate and successfully use a company’s software.

Claims-intelligence software that helps health plans review and prevent improper payments against coverage rules and policy language.

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

A factory-orchestration platform connects workers, machines and business systems to coordinate production in real time.

Blee gives legal, compliance and marketing teams an AI-assisted system to review promotional content against their rules before publication and monitor websites, social media and partner channels afterward.

Building small nuclear reactors on floating barges for clean power to ports and nearby infrastructure

Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027.

Fab2 develops chipmaking equipment and design software to shorten the path from chip design to fabrication.

BrainChild Bio develops CAR T-cell therapies for tumors in the central nervous system, including pediatric brain cancers and glioblastoma.